Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Financial News

Affinium adds $15M in B round

August 31, 2011 12:24 AM UTC

Affinium Pharmaceuticals Ltd. (Austin, Texas) raised $15 million in a series B round. New investor Ontario Emerging Technologies Fund (OETF) joined existing investors SV Life Sciences; Genesis Capital; and Forward Ventures in the round. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article